Product Details
| Product Name:
Inogatran |
CAS No.:
155415-08-0 |
| Supply Ability:
10g |
Release date:
2025/08/22 |
Product Introduction
Bioactivity
| Name | Inogatran |
| Description | Inogatran is a synthetic thrombin inhibitor, developed for the possible treatment and prophylaxis of venous and arterial thrombotic diseases. |
| In vivo | Inogatran enhances vena caval blood circulation and diminishes the frequency of thrombotic occlusions in rat studies. Administered intravenously in a canine model of venous thrombosis at dosages of 0.075, 0.25, and 0.75 mg/kg, Inogatran (H-314-27) exhibits a dose-dependent augmentation in activated partial thromboplastin time (aPTT), thrombin time (TT), and prothrombin time (PT), indicative of its anticoagulant effects. This corresponds with a dose-related inhibition of thrombus formation, evidenced by extended time to occlusion (TTO) and reduced thrombus mass. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Inogatran |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$2120.00
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-14 |
United States